Author Correction: Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors.
Peitao ZhangHaixia GuanShukai YuanHuili ChengJian ZhengZhenlei ZhangYifan LiuYang YuZhaowei MengXiangqian ZhengLi ZhaoPublished in: Nature communications (2022)